Clinical trials: Overactive Bladder Associated With HTLV-1
Overactive Bladder Associated With HTLV-1
A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
It's a double blind, placebo controlled study to assess the efficacy of Propantheline Bromide to treat overactive bladder (OAB) in HTLV 1 infected patients.
- Trial name
- NCT01640002
- Testing
- Propantheline Bromide
- Where
- Brazil
- Volunteers
- 42 people
- Sponsor
- Hospital Universitário Professor Edgard Santos